Nutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, 305C, Medical Science Building, Callaghan, NSW 2308, Australia.
Hunter Medical Research Institute, University of Newcastle, New Lambton, NSW 2035, Australia.
Nutrients. 2021 Nov 16;13(11):4099. doi: 10.3390/nu13114099.
Excessive adiposity is a major risk factor for type 2 diabetes (T2D), and dietary patterns are important determinants of weight status. Plant-based dietary patterns (PBDs) are known for their therapeutic effects on T2D. The aim is to systematically review RCTs to investigate the effects of various PBDs compared to regular meat-eating diets (RMDs), in individuals who normally consume a RMD on body weight, BMI, and waist circumference in T2D. RCTs investigating PBDs and body weight, BMI, WC for ≥6 weeks in adults with T2D since 1980 were eligible for inclusion. Seven trials ( = 269) were included in the meta-analysis using random-effects models and expressed as MD (95%Cls). Compared to RMDs, PBDs significantly lowered body weight (-2.35 kg, 95% CI: -3.51, -1.19, < 0.001), BMI (-0.90 kg/m, 95% CI: -1.42, -0.38, = 0.001) and WC (-2.41 cm, 95% CI: -3.72, -1.09, < 0.001). PBDs alone significantly reduced body weight by 5.1% (-4.95 kg, 95% CI: -7.34, -2.55, < 0.001), BMI by 5.4% (-1.87 kg/m, 95% CI: -2.78, -0.95, < 0.001) and WC by 4.3%(-4.23, 95% CI: -6.38, -2.07, < 0.001). Interventions not limiting energy intake led to a significant reduction in body weight (-2.54 kg, 95% CI: -4.16, -0.92, < 0.005) and BMI (-0.91 kg/m, 95% CI: -1.56, -0.25, < 0.005). Trials ≥16 weeks had a pronounced reduction in body weight (-2.93 kg, 95% CI: -5.00, -0.87, = 0.005) and BMI (-1.13 kg/m, 95% CI: -1.89, -0.38, < 0.005). These findings provide evidence for the implementation of PBDs for better management of central adiposity in individuals with T2D.
过量的体脂是 2 型糖尿病(T2D)的一个主要危险因素,而饮食模式是体重状况的重要决定因素。植物性饮食模式(PBD)以其对 T2D 的治疗效果而闻名。本研究旨在系统综述 RCT,以调查与常规肉食饮食(RMD)相比,各种 PBD 对 T2D 患者体重、BMI 和腰围的影响。自 1980 年以来,对 PBD 与体重、BMI、WC 相关的、针对成年人 T2D 的 RCT,且干预时间 ≥6 周的研究符合纳入标准。使用随机效应模型对 7 项试验(=269 人)进行荟萃分析,并表示为 MD(95%CI)。与 RMD 相比,PBD 显著降低体重(-2.35kg,95%CI:-3.51,-1.19,<0.001)、BMI(-0.90kg/m,95%CI:-1.42,-0.38,=0.001)和 WC(-2.41cm,95%CI:-3.72,-1.09,<0.001)。PBD 单独使用时,体重显著降低 5.1%(-4.95kg,95%CI:-7.34,-2.55,<0.001)、BMI 降低 5.4%(-1.87kg/m,95%CI:-2.78,-0.95,<0.001)和 WC 降低 4.3%(-4.23cm,95%CI:-6.38,-2.07,<0.001)。不限制能量摄入的干预措施导致体重(-2.54kg,95%CI:-4.16,-0.92,<0.005)和 BMI(-0.91kg/m,95%CI:-1.56,-0.25,<0.005)显著降低。干预时间≥16 周时,体重(-2.93kg,95%CI:-5.00,-0.87,=0.005)和 BMI(-1.13kg/m,95%CI:-1.89,-0.38,<0.005)明显降低。这些发现为在 T2D 患者中实施 PBD 以更好地管理中心性肥胖提供了证据。